Increased serum S100B protein in schizophrenia: A study in medication-free patients

Journal of Psychiatric Research

Volumn 35, Issue 1, 2001, Pages 11-14

  Lara, D R ^a,b   Gama, C S ^b   Belmonte De Abreu, P ^b   Portela, L V C ^a,c   Goncalves C A ^a   Fonseca, M ^b   Hauck, S ^b   Souza, D O ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Public Laboratory of Novo Hamburgo   (Brazil)

Author keywords

Astrocytes; Glia; Neurodegeneration; S100B protein; Schizophrenia

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM BINDING PROTEIN; PROTEIN S 100; PROTEIN S100B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROGLIA; S100 PROTEINS; SCHIZOPHRENIA;

EID: 0035085349     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00003-6     Document Type: Article

References (20)

1. Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis
2. Mind glue: implications of glial cell biology for psychiatry
3. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type
4. Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia
5. Decreased S100B protein in schizophrenia: preliminay evidence
6. Extracellular S100B Protein Modulates ERK in Astrocyte Cultures
7. A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid
8. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
9. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures
10. Schizophrenia as a membrane lipid disorder which is expressed throughout the body
11. S100beta induces neuronal cell death through nitric oxide release from astrocytes
12. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome
13. The positive and negative syndrome scale (PANSS) for schizophrenia
14. Schizophrenia: a purinergic hypothesis
15. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia
16. Psychobiologic correlates of treatment response in schizophrenia
17. S100 beta as a neurotrophic factor
18. Schizophrenia as a developmental disorder of the cerebral cortex
19. The highly integrated dialogue between neurons and astrocytes in brain function
20. Elevated plasma levels of S-100b protein in schizophrenic patients